BRCA1 and neoplasm: An association was shown at the tendency level: in the general group of patients (Figure 1A) and in those treated with the anthracycline-containing regimen (Figure 1B), the levels of BRCA1 expression were higher in patients with tumor progression during treatment compared with the group of patients showing objective treatment responses (p = 0.07).